Can You Trust HSBC Holdings plc’s Dividend Or Should You Pick GlaxoSmithKline plc?

Is HSBC Holdings plc (LON: HSBA) a better income investment than GlaxoSmithKline plc (LON: GSK)?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

HSBC (LSE: HSBA) and GlaxoSmithKline (LSE: GSK) are two of the FTSE 100’s dividend champions. HSBC’s shares currently support a dividend yield of 8.5%, and Glaxo’s shares support a dividend yield of 5.4%.

The question is, can these yields be trusted? 

Can you trust the yields? 

Investors are often advised to give the largest yields on the market a wide berth as a larger-than-average dividend yield often indicates that the payout isn’t sustainable. Although this isn’t always the case. 

Following a strategy of buying the highest yielding FTSE 100 stocks can generate some impressive results over time, but this strategy isn’t for the fainthearted. Indeed, as we’ve seen over the past 12 months, even those payouts previously considered safe can be cut at a moment’s notice.

Still, HSBC’s management has gone out of its way to reassure investors that the current dividend payout is here to stay for the foreseeable future. Specifically, on the bank’s fourth-quarter and full-year 2015 earnings conference call, Ian Mackay, finance director of HSBC told the listening analysts that a dividend cut last year was never, ever on the cards. When asked what would have to happen for the dividend to be cut, Mackay said, “the last time we cut the dividend was in the teeth of the global financial crisis when we had to do a rights issue and were sitting on $160bn of US sub prime mortgages.” In other words, HSBC is only likely to cut its dividend payout if a sudden global economic crisis emerges. The problem with this statement is that the last time around, few saw the crisis coming, and it’s highly likely the next crisis will also be a complete surprise.

The bank posted a net loss of £878m for the fourth quarter of 2015, much worse than expected, and that translated to a fall of 1.2% in annual profits for the year.

Here to stay 

On the other hand, Glaxo’s dividend is unlikely to be cut if/when the next global economic crisis takes the world by storm. The defensive nature of Glaxo’s business means that the company’s cash flows are relatively stable throughout all stages of the economic cycle, unlike HSBC, which as a bank is a highly cyclical business. So, in theory, Glaxo’s dividend payout should be more sustainable than that of HSBC.

What’s more, management has guaranteed that the company’s 80p per share annual dividend payout is here to stay for the time being so a dividend yield of 5.4% looks safe. The group is on track to achieve annualised cost savings of £3bn by the end of 2017 and with around 4.9bn shares in issue, a dividend of 80p per share per annum is costing Glaxo around £3.9bn per annum to maintain. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves owns shares of GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline and HSBC Holdings. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Asian woman holding a cup of takeaway coffee and folders containing paperwork, on her way into the office
Investing Articles

How I could make a 10% yield for high passive income a reality

Jon Smith explains how he can target high passive income from top-yielding stocks, including one specific example he'd consider.

Read more »

Investing Articles

I’d buy 1,784 shares of this FTSE 100 stock to target £350 of monthly passive income

Muhammad Cheema takes a look at how British American Tobacco shares, with a dividend yield of 10.1%, can generate a…

Read more »

White female supervisor working at an oil rig
Investing Articles

1 ex-FTSE 100 stock that I think will get promoted soon

Jon Smith flags up an energy stock that used to be in the FTSE 100 and currently has strong momentum…

Read more »

Shot of a young Black woman doing some paperwork in a modern office
Investing Articles

With an 8% dividend yield, I think this undervalued FTSE stock is a no-brainer buy

With an impressive yield and good track record of payments, Mark David Hartley is considering adding this promising FTSE share…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

£9,500 in savings? Here’s how I’d try to turn that into £1,809 a month of passive income

Investing a relatively small amount into high-yielding stocks and reinvesting the dividends paid can generate significant passive income over time.

Read more »

Businesswoman analyses profitability of working company with digital virtual screen
Investing Articles

Dividend star Legal & General’s share price is still marked down, so should I buy more?

Legal & General’s share price looks very undervalued against its peers. But it pays an 8%+ dividend yield, and has…

Read more »

Investing Articles

Dividend shares: 1 FTSE 100 stock to consider buying for chunky shareholder income

This company’s ‘clean’ dividend record looks attractive to me and I’d consider buying some of the shares to hold long…

Read more »

Investing Articles

3 of my top FTSE 250 stocks to consider buying before April

Buying undervalued UK shares can be a great way to generate long-term wealth. Here, Royston Wild reveals a handful on…

Read more »